Form 8-K - Current report:
SEC Accession No. 0001564590-20-014775
Filing Date
2020-04-01
Accepted
2020-04-01 16:06:58
Documents
14
Period of Report
2020-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-8k_20200401.htm   iXBRL 8-K 47719
2 EX-99.1 - PRESS RELEASE ISSUED APRIL 1, 2020, REPORTING POSITIVE TOPLINE DATA FO arna-ex991_6.htm EX-99.1 24373
3 GRAPHIC gtedy4m302i5000001.jpg GRAPHIC 7285
  Complete submission text file 0001564590-20-014775.txt   217166

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20200401.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200401_lab.xml EX-101.LAB 18706
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200401_pre.xml EX-101.PRE 11179
7 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20200401_htm.xml XML 3430
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

EIN.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 20765460
SIC: 2834 Pharmaceutical Preparations